Sign inJoin waitlistJoin the waitlist

SM

Swaminathan Murugappan

Hematology & Oncology

Credentials: · ·

History

Hematology and Medical Oncology
Internal Medicine

Research

Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1-derived oncolytic immunotherapy
Review · Expert Review of Anticancer Therapy · 2015 · 107 citations
PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell…
Oral Oncology · 2016 · Last of 11 authors · 24 citations
PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
Head & Neck · 2016 · Last of 8 authors · 17 citations

Douglas Adkins
2 papers
Christopher Willett
1 paper
DS
David Spigel
1 paper
EL
Edward Lin
1 paper
HK
Howard Kaufman
1 paper
Igor Puzanov
1 paper
LW
Lori Wirth
1 paper
Paul O'Brien
1 paper
Randolph Hecht
1 paper
Richard Wein
1 paper
RA
Rita Axelrod
1 paper
SD
Shaker Dakhil
1 paper